Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata

Bader, JC; Lakota, EA; Flanagan, S; Ong, V; Sandison, T; Rubino, CM; Bhavnani, SM; Ambrose, PG

Bader, JC (reprint author), Inst Clin Pharmacodynam Inc, Schenectady, NY 12305 USA.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018; 62 (6):

Abstract

Rezafungin (CD101) is a novel echinocandin antifungal agent with activity against Aspergillus and Candida species, including azole- and echinocandin-r......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索